Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-10-035320
Filing Date
2010-06-23
Accepted
2010-06-23 12:26:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 40447
  Complete submission text file 0000000000-10-035320.txt   57236
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filed for) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)